The position of drospirenone in premenstrual syndrome teratment

Overview

Objective:
To evaluate influence of hormonal contraceptive drospirenone on premenstrual syndrome (PMS).

Design:
Overall summary of literature.

Author affiliation:
ADC Sanatorium, Praha.

Methods:
Review of scientific studies and publications.

Conclusions:
The author submitted current opinions on premenstrual syndrome, its classification, and treatment. The role of renin – aldosterone system in the genesis of PMS was described. Basic pharmacological characteristics of the remedy containing in one pill 30 μg of Ethinyl Estradiol (EE) and 3 mg of drospirenone are presented. Its therapeutic effects on somatic and psychological PMS symptoms are discussed.

Key words:
premenstrual syndrome – body weight – oedema – drospirenone.